Page last updated: 2024-08-21

pyrazines and monocrotaline

pyrazines has been researched along with monocrotaline in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's0 (0.00)29.6817
2010's1 (20.00)24.3611
2020's3 (60.00)2.80

Authors

AuthorsStudies
Cui, S; Ding, W; Wang, B; Yang, B; Zhou, C1
Huh, JW; Kim, HJ; Kim, SY; Lee, JH; Lee, SD; Lee, YS; Oh, YM; Park, MK; Ro, JY1
Black, SM; Chen, J; Chen, X; Chen, Y; Desai, AA; Duan, X; Garcia, JGN; He, W; Hong, C; Hou, C; Kuang, M; Li, M; Liao, J; Liu, C; Liu, S; Lu, W; Makino, A; Rischard, F; Tang, H; Vanderpool, RR; Wang, J; Wu, X; Yang, K; Yuan, JX; Zhang, J; Zhang, N; Zhang, Z; Zheng, Q; Zhong, N; Zou, G1
Bialesova, L; Bouchard, A; Kinsella, BT; Mulvaney, EP; Reid, HM; Salvail, D1
Bai, YZ; Cao, YQ; Dong, WP; Dong, Z; Liu, Y; Ma, XM; Wang, XW; Yang, B; Yang, DP; Yang, YC; Zeng, YY1

Other Studies

5 other study(ies) available for pyrazines and monocrotaline

ArticleYear
[Observation of relationship between function and structure of experimental pulmonary artery hypertension in rats and inhibitory effect of garlicin and other herbal medicines].
    Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae, 1996, Volume: 18, Issue:6

    Topics: Alkaloids; Allyl Compounds; Animals; Antihypertensive Agents; Benzylisoquinolines; Blood Pressure; Disulfides; Hypertension, Pulmonary; Male; Monocrotaline; Pulmonary Artery; Pyrazines; Random Allocation; Rats; Rats, Wistar; Vasodilator Agents

1996
Bortezomib alleviates experimental pulmonary arterial hypertension.
    American journal of respiratory cell and molecular biology, 2012, Volume: 47, Issue:5

    Topics: Animals; Boronic Acids; Bortezomib; Caspase 3; Cell Hypoxia; Cell Proliferation; Cells, Cultured; Endothelial Cells; Endothelium, Vascular; Heart Ventricles; Humans; Hypertension, Pulmonary; Liver; Liver Function Tests; Male; Mice; Mice, Inbred C57BL; Monocrotaline; Nitric Oxide Synthase Type III; Proteasome Inhibitors; Pulmonary Artery; Pyrazines; Rats; Rats, Sprague-Dawley

2012
Tetramethylpyrazine: A promising drug for the treatment of pulmonary hypertension.
    British journal of pharmacology, 2020, Volume: 177, Issue:12

    Topics: Animals; Cell Proliferation; Disease Models, Animal; Humans; Hypertension, Pulmonary; Monocrotaline; Myocytes, Smooth Muscle; Pharmaceutical Preparations; Pulmonary Artery; Pyrazines; Rats; Rats, Sprague-Dawley

2020
NTP42, a novel antagonist of the thromboxane receptor, attenuates experimentally induced pulmonary arterial hypertension.
    BMC pulmonary medicine, 2020, Apr-06, Volume: 20, Issue:1

    Topics: Acetamides; Animals; Antihypertensive Agents; Disease Models, Animal; Heart Ventricles; Hemodynamics; Humans; Hypertrophy, Right Ventricular; Male; Monocrotaline; Pulmonary Arterial Hypertension; Pulmonary Artery; Pyrazines; Rats; Rats, Inbred WKY; Receptors, Thromboxane; Sildenafil Citrate; Vascular Remodeling

2020
Tetramethylpyrazine Improves Monocrotaline-Induced Pulmonary Hypertension through the ROS/iNOS/PKG-1 Axis.
    Journal of healthcare engineering, 2022, Volume: 2022

    Topics: Animals; Hypertension, Pulmonary; Monocrotaline; Nitric Oxide Synthase Type II; Protein Kinases; Pyrazines; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species

2022